推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733，021-33632861

chinasupport@letpub.com

登录 注册 新注册优惠

Chinese Journal of Cancer Research

2023年12月最新中科院分区表数据已经更新，欢迎查询！ 如果您对期刊系统有任何需求或者问题，欢迎点击此处反馈给我们。

按期刊名首写字母查看 CHINESE J CANCE最新评论：有的，不登录系统都不知道杂志要小修。。。 (2023-10-20)


期刊名:   ISSN:   研究方向:   影响因子: -   SCI收录:
大类学科:   小类学科:   中科院分区:   是否OA期刊:   结果排序:

同行评审状态查询 Manuscript Number * Last Name * First Name * 出版社 * 查 询 重 置

按研究方向查看：


Chinese Journal of Cancer Research期刊基本信息Hello，您是该期刊的第40337位访客


基本信息 登录收藏
期刊名字Chinese Journal of Cancer ResearchChinese Journal of Cancer Research

CHINESE J CANCER RES
（此期刊被最新的JCR期刊SCIE收录）

LetPub评分
7.0
50人评分
我要评分

声誉
8.7

影响力
5.6

速度
7.0

期刊ISSN1000-9604
微信扫码收藏此期刊
E-ISSN1993-0631
2022-2023最新影响因子
（数据来源于搜索引擎）		5.1 点击查看影响因子趋势图
实时影响因子 截止2024年3月26日：4.374
2022-2023自引率9.80%点击查看自引率趋势图
五年影响因子5
h-index 暂无h-index数据
CiteScore 暂无CiteScore数据
期刊简介
Chinese Journal of Cancer Research (CJCR; Print ISSN: 1000-9604; Online ISSN:1993-0631; www.thecjcr.org) is published by AME Publishing Company (www.amepc.org) in association with Chinese Anti-Cancer Association.It was launched in March 1995 as a quarterly publication and is now published bi-monthly since February 2013.

CJCR is published bi-monthly in English, and is an international journal devoted to the life sciences and medical sciences. It publishes peer-reviewed original articles of basic investigations and clinical observations, reviews and brief communications providing a forum for the recent experimental and clinical advances in cancer research. This journal is indexed in Science Citation Index Expanded (SCIE), PubMed/PubMed Central (PMC), Scopus, SciSearch, Chemistry Abstracts (CA), the Excerpta Medica/EMBASE, Chinainfo, CNKI, CSCI, etc.
期刊官方网站https://www.springer.com/journal/11670
期刊投稿网址https://mc03.manuscriptcentral.com/cjcr
期刊语言要求Language
Presenting your work in a well-structured manuscript and in well-written English gives it its best chance for editors and reviewers to understand it and evaluate it fairly. Many researchers find that getting some independent support helps them present their results in the best possible light.

经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件，不仅能满足Chinese Journal of Cancer Research的语言要求，还能让Chinese Journal of Cancer Research编辑和审稿人得到更好的审稿体验，让稿件最大限度地被Chinese Journal of Cancer Research编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）帮助作者准备稿件，已助力全球15万+作者顺利发表论文。部分发表范例可查看：服务好评 论文致谢 。
提交文稿
是否OA开放访问No
通讯方式SPRINGER, 233 SPRING ST, NEW YORK, USA, NY, 10013
出版商Springer Berlin Heidelberg
涉及的研究方向医学-肿瘤学
出版国家或地区PEOPLES R CHINA
出版语言English
出版周期Quarterly
出版年份1988
年文章数 44点击查看年文章数趋势图
Gold OA文章占比98.86%
研究类文章占比：
文章 ÷（文章 + 综述）		84.09%
WOS期刊SCI分区
（ 2022-2023年最新版）		WOS分区等级：2区

按学科分区JIF分区JIF排名JIF百分位
学科：ONCOLOGY
类别：SCIE		Q276/241
中科院《国际期刊预警
名单（试行）》名单 		2024年02月发布的2024版：不在预警名单中

2023年01月发布的2023版：不在预警名单中

2021年12月发布的2021版：不在预警名单中

2020年12月发布的2020版：不在预警名单中
中科院SCI期刊分区
（ 2023年12月最新升级版） 		点击查看中科院SCI期刊分区趋势图
大类学科小类学科Top期刊综述期刊
医学 1区2区1区
ONCOLOGY
肿瘤学		1区4区3区
否否
中科院SCI期刊分区
（ 2022年12月升级版）
大类学科小类学科Top期刊综述期刊
医学 3区3区3区
ONCOLOGY
肿瘤学		3区2区3区
否否
中科院SCI期刊分区
（ 2021年12月旧的升级版）
大类学科小类学科Top期刊综述期刊
医学 4区2区2区
ONCOLOGY
肿瘤学		1区1区2区
否否
SCI期刊收录coverage Science Citation Index Expanded (SCIE) (2020年1月，原SCI撤销合并入SCIE，统称SCIE)
PubMed Central (PMC)链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1000-9604%5BISSN%5D
平均审稿速度网友分享经验：
平均4.5月
平均录用比例网友分享经验：
约62.5%
LetPub助力发表经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍，平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）后论文在Chinese Journal of Cancer Research顺利发表。
快看看作者怎么说吧：服务好评 论文致谢
期刊常用信息链接
同领域相关期刊 Chinese Journal of Cancer Research期刊近年CiteScore指标趋势图
该杂志的自引率趋势图 Chinese Journal of Cancer Research中科院SCI期刊分区趋势图
该杂志的年文章数趋势图 同领域作者分享投稿经验
Chinese Journal of Cancer Research上中国学者近期发表的论文  
  • 同领域相关期刊
  • 期刊CiteScore趋势图
  • 期刊自引率趋势图
  • 中科院SCI期刊分区趋势图
  • 年文章数趋势图
  • 该期刊中国学者近期发表论文
  • 中科院SCI期刊分区相关期刊
  • 同类著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144642.90
    Nature Reviews Clinical Oncology12775.50
    NATURE REVIEWS CANCER39696.70
    LANCET ONCOLOGY27462.00
    ANNALS OF ONCOLOGY21063.00
    CANCER CELL29552.90
    JOURNAL OF CLINICAL ONCOLOGY49439.60
    SEMINARS IN CANCER BIOLOGY13420.00
    CANCER TREATMENT REVIEWS11620.70
    CLINICAL CANCER RESEARCH29221.80
    中科院SCI期刊分区同大类学科的热搜期刊 浏览次数
    MEDICINE609973
    BIOMATERIALS519878
    BIOMEDICINE & PHARMACOTHERAPY473425
    Journal of Materials Chemistry B464817
    Frontiers in Pharmacology457675
    Frontiers in Immunology429618
    JOURNAL OF ETHNOPHARMACOLOGY412171
    COLLOIDS AND SURFACES B-BIOINTERFACES408008
    Frontiers in Oncology389912
    Acta Biomaterialia381142
  •  

    Chinese Journal of Cancer Research Chinese Journal of Cancer Research
    我来预测明年：
    稳步上升 表现平稳 逐渐下降　 刷新
  •  

    		  
  •  

    		  
  •  

    		  
  • 中国学者近期发表的论文
    1.Incidence and mortality of primary bone cancers in China, 2014.

    Author: Xia L1, Zheng R2, Xu Y1, Xu X1, Zhang S2, Zeng H2, Lin L1, Chen W2.
    Journal: Chin J Cancer Res. 2019 Feb;31(1):135-143. doi: 10.21147/j.issn.1000-9604.2019.01.08.        PubMed      DOI
    2.Incidence and mortality of thyroid cancer in China, 2008-2012.

    Author: Du L1, Li R1, Ge M1, Wang Y1, Li H1, Chen W2, He J2.
    Journal: Chin J Cancer Res. 2019 Feb;31(1):144-151. doi: 10.21147/j.issn.1000-9604.2019.01.09.        PubMed      DOI
    3.Clinical features and outcomes of diffuse large B-cell lymphoma based on nodal or extranodal primary sites of origin: Analysis of 1,085 WHO classified cases in a single institution in China.

    Author: Shi Y1, Han Y1, Yang J1, Liu P1, He X1, Zhang C1, Zhou S1, Zhou L1, Qin Y1, Song Y2, Liu Y2, Wang S2, Jin J2, Gui L1, Sun Y1.
    Journal: Chin J Cancer Res. 2019 Feb;31(1):152-161. doi: 10.21147/j.issn.1000-9604.2019.01.10.        PubMed      DOI
    4.Prognostic value of 18F-fluorodeoxyglucose positron emission tomography using Deauville criteria in diffuse large B cell lymphoma treated with autologous hematopoietic stem cell transplantation.

    Author: Ying Z1, Mi L2, Zhou N3, Wang X3, Yang Z3, Song Y1, Wang X1, Zheng W1, Lin N1, Tu M1, Xie Y1, Ping L1, Zhang C1, Liu W1, Deng L1, Zhu J1.
    Journal: Chin J Cancer Res. 2019 Feb;31(1):162-170. doi: 10.21147/j.issn.1000-9604.2019.01.11.        PubMed      DOI
    5.Metastatic patterns and surgical methods for lymph nodes No. 5 and No. 6 in proximal gastric cancer.

    Author: Wang J1, Wu P2, Wang Z2, Li K2, Huang B2, Wang P2, Xu H2, Zhu Z2.
    Journal: Chin J Cancer Res. 2019 Feb;31(1):171-177. doi: 10.21147/j.issn.1000-9604.2019.01.12.        PubMed      DOI
    6.Risk-stratification model to select conversion surgery for advanced gastric cancer patients.

    Author: Nie R1, Yuan S1, Li Y1, Chen S2, Li S3, Yang L1, Yang L1, Chen Y1, Zhou Z1.
    Journal: Chin J Cancer Res. 2019 Feb;31(1):178-187. doi: 10.21147/j.issn.1000-9604.2019.01.13.        PubMed      DOI
    7.Prognostic implications of epidermal growth factor receptor variant III expression and nuclear translocation in Chinese human gliomas.

    Author: Yang K1,2,3, Ren X1,2,3, Tao L4, Wang P5,6, Jiang H1,2,3, Shen L5,6, Zhao Y4, Cui Y1,2,3, Li M1,2,3, Lin S1,2,3.
    Journal: Chin J Cancer Res. 2019 Feb;31(1):188-202. doi: 10.21147/j.issn.1000-9604.2019.01.14.        PubMed      DOI
    8.STIM1 expression is associated with osteosarcoma cell survival.

    Author: Zang J1,2, Zuo D1,3, Shogren KL1, Gustafson CT1, Zhou Z1, Thompson MA4, Guo R5, Prakash YS3,6, Lu L1,6, Guo W2, Maran A1,6, Yaszemski MJ1,6.
    Journal: Chin J Cancer Res. 2019 Feb;31(1):203-211. doi: 10.21147/j.issn.1000-9604.2019.01.15.        PubMed      DOI
    9.Colorectal cancer, radiotherapy and gut microbiota.

    Author: Zhang S1, Wang Q1, Zhou C1, Chen K1, Chang H1, Xiao W1, Gao Y1.
    Journal: Chin J Cancer Res. 2019 Feb;31(1):212-222. doi: 10.21147/j.issn.1000-9604.2019.01.16.        PubMed      DOI
    10.A phase I study of nimotuzumab plus docetaxel in chemotherapy-refractory/resistant patients with advanced non-small-cell lung cancer.

    Author: Zhao J, Zhuo M, Wang Z, Duan J, Wang Y, Wang S, An T, Wu M, Wang J.
    Journal: Chin J Cancer Res. 2016 Feb;28(1):12-8. doi: 10.3978/j.issn.1000-9604.2016.02.07.        PubMed  
  • 同大类学科的其他著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144642.90
    LANCET700133.20
    NEW ENGLAND JOURNAL OF MEDICINE933134.40
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION62245.40
    NATURE REVIEWS DRUG DISCOVERY289123.80
    BMJ-British Medical Journal015.30
    BMJ-British Medical Journal015.30
    NATURE REVIEWS IMMUNOLOGY35183.00
    NATURE MEDICINE497107.50
    Nature Reviews Disease Primers4860.90
    同分区等级的其他期刊名称 h-index CiteScore
    Living Reviews in Relativity065.50
    Living Reviews in Relativity7565.50
    JOURNAL OF TRAVEL MEDICINE5119.60
    Military Medical Research030.10
    Advanced Composites and Hybrid Materials016.90
    INTERNATIONAL JOURNAL OF COMPUTER VISION17222.50
    Eurosurveillance9027.70
    JOURNAL OF THE ROYAL SOCIETY OF MEDICINE715.70
    Small Structures00.00
    Trends in Chemistry032.10


以上SCI期刊相关数据和信息来源于网络，仅供参考。
投稿状态统计： 我要评分：

    同领域作者分享投稿经验：共34条 （包含回复）

 我来分享

    联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

    © 2010-2024 中国: LetPub上海分公司    网站备案号：沪ICP备10217908号-1    沪公网安备号：31010402006960

    增值电信业务经营许可证：沪B2-20211595

    礼翰商务信息咨询（上海）有限公司      办公地址：上海市徐汇区漕溪北路88号圣爱大厦1803室

    United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451